Jove
Visualize
Contact Us

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ABC of sealing following left atrial appendage closure.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Socioeconomic disparities in long-term mortality after infective endocarditis in Denmark: a nationwide cohort study.

The Lancet regional health. Europe·2026
Same author

Functional capacity and skeletal muscle morphology are linked to N-terminal proBNP but not left ventricular ejection fraction in patients with heart failure.

American journal of physiology. Heart and circulatory physiology·2025
Same author

Incidence rate of infective endocarditis by socioeconomic position: a Danish nationwide cohort study (2000-2022).

The Lancet regional health. Europe·2025
Same author

Temporal changes in characteristics, incidence, and mortality in patients undergoing surgical intervention for mitral stenosis.

Scientific reports·2024
Same author

Influence of intensive lipid-lowering on CT derived fractional flow reserve in patients with stable chest pain: Rationale and design of the FLOWPROMOTE study.

Clinical cardiology·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 17, 2026

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

Remote ischemic conditioning: the cardiologist's perspective.

Michael R Schmidt1, Astrid D Sloth, Jacob Johnsen

  • 1Department of Cardiology, Aarhus University Hospital Skejby, Brendstrupgaardsvej, Aarhus N, Denmark.

Journal of Cardiovascular Medicine (Hagerstown, Md.)
|November 2, 2012
PubMed
Summary

Remote ischemic conditioning (RIC) protects the heart from injury during reperfusion after a heart attack. This noninvasive technique shows promise for reducing heart damage and improving outcomes in acute coronary syndromes.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Model of Ischemia and Reperfusion Injury in Rabbits
06:11

Model of Ischemia and Reperfusion Injury in Rabbits

Published on: November 3, 2023

Related Experiment Videos

Last Updated: May 17, 2026

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Model of Ischemia and Reperfusion Injury in Rabbits
06:11

Model of Ischemia and Reperfusion Injury in Rabbits

Published on: November 3, 2023

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Regenerative Medicine

Background:

  • Myocardial reperfusion is crucial after ischemic events but can cause further damage (ischemia-reperfusion injury).
  • Existing treatments require new strategies to protect the heart from ischemia-reperfusion injury in coronary artery disease.

Purpose of the Study:

  • To explore remote ischemic conditioning (RIC) as a therapeutic strategy against myocardial ischemia-reperfusion injury.
  • To assess the clinical potential of noninvasive RIC in patients with cardiovascular conditions.

Main Methods:

  • Remote ischemic conditioning (RIC) involves brief, nonlethal episodes of ischemia and reperfusion in a remote organ (e.g., limb).
  • Noninvasive RIC utilizes a blood pressure cuff on the upper arm to induce limb ischemia and reperfusion.
  • Clinical studies and trials are evaluating the efficacy and application of RIC.

Main Results:

  • RIC activates innate cardioprotective mechanisms.
  • Recent proof-of-concept studies show encouraging results for RIC.
  • RIC may dramatically reduce infarct size, especially in acute coronary syndromes.

Conclusions:

  • Remote ischemic conditioning (RIC) is a promising, noninvasive strategy to mitigate myocardial ischemia-reperfusion injury.
  • Large-scale trials are needed to confirm RIC's role in clinical practice.
  • RIC holds potential for improving outcomes in acute coronary syndromes, cardiac arrest, and stroke.